Floatz logo

Tropicamide

Sialorrhea (Excessive Drooling)

NeuroHealing Pharmaceuticals Inc.Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Sialorrhea (Excessive Drooling) cohort.

Asset / SponsorPhaseRating
Botulinum Toxin Type B
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
Phase 2NR

Same molecule, other indications

Tropicamide is also rated in:

Parkinson diseaseDormant
B
Indicative ·
57 / 100
View asset →
Fabry diseaseDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →